• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠脊髓突触体膜中5-羟色胺3受体结合位点的鉴定。

Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes.

作者信息

Glaum S R, Anderson E G

机构信息

Department of Pharmacology, University of Illinois, Chicago 60612.

出版信息

Eur J Pharmacol. 1988 Nov 1;156(2):287-90. doi: 10.1016/0014-2999(88)90335-4.

DOI:10.1016/0014-2999(88)90335-4
PMID:3240771
Abstract

The 5-HT3 receptor antagonists, ICS 205-930 and MDL 72222, displace 47-55% of the specific [3H]serotonin (100 nM) binding to synaptosomal membranes derived from the dorsal, but not ventral, spinal cord of rats with IC50s less than 1.0 nM. Methiothepin (10 microM) increased displacement to 86-94% without shifting these IC50s. Scatchard plots of [3H]5-HT binding in the presence of methiothepin (10 microM) reveal a single population of sites (KD = 11.5 nM, Bmax = 282 fmol mg-1 protein). These results indicate the presence of 5-HT3 binding sites in dorsal spinal cord.

摘要

5-羟色胺3(5-HT3)受体拮抗剂ICS 205-930和MDL 72222能够取代47%-55%与大鼠背侧而非腹侧脊髓来源的突触体膜特异性结合的[3H]血清素(100 nM),其半数抑制浓度(IC50)小于1.0 nM。甲硫哒嗪(10 μM)可使取代率提高至86%-94%,而不改变这些IC50值。在存在甲硫哒嗪(10 μM)的情况下,[3H]5-羟色胺结合的Scatchard图显示为单一的位点群体(解离常数KD = 11.5 nM,最大结合容量Bmax = 282 fmol mg-1蛋白质)。这些结果表明在背侧脊髓中存在5-HT3结合位点。

相似文献

1
Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes.大鼠脊髓突触体膜中5-羟色胺3受体结合位点的鉴定。
Eur J Pharmacol. 1988 Nov 1;156(2):287-90. doi: 10.1016/0014-2999(88)90335-4.
2
5-HT3 receptors are not involved in the modulation of the K(+)-evoked release of [3H]5-HT from spinal cord synaptosomes of rat.5-羟色胺3型受体不参与调节钾离子诱发的大鼠脊髓突触体中[3H]5-羟色胺的释放。
Neuropharmacology. 1992 Aug;31(8):725-33. doi: 10.1016/0028-3908(92)90033-l.
3
Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.通过[125I]碘氰吲哚洛尔结合及对[3H]-5-羟色胺释放的抑制作用对大鼠脊髓中5-羟色胺1B受体进行表征
J Pharmacol Exp Ther. 1992 Feb;260(2):614-26.
4
Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.使用[3H]-喹哌嗪和[3H]-GR65630结合法研究NG108-15、NCB-20神经母细胞瘤细胞及大鼠大脑皮层中5-HT3结合位点的特征
Br J Pharmacol. 1991 Apr;102(4):919-25. doi: 10.1111/j.1476-5381.1991.tb12277.x.
5
Identification of lymphocyte 5-HT3 receptor subtype and its implication in fish T-cell proliferation.淋巴细胞5-羟色胺3受体亚型的鉴定及其在鱼类T细胞增殖中的意义。
Immunol Lett. 1997 Mar;55(3):151-60. doi: 10.1016/s0165-2478(97)02697-7.
6
[3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain.[3H]季铵化ICS 205 - 930标记大鼠脑中的5 - HT3受体结合位点。
Eur J Pharmacol. 1988 May 10;149(3):397-8. doi: 10.1016/0014-2999(88)90677-2.
7
Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo.5-HT1B和5-HT3受体在体内对大鼠海马体中5-羟色胺释放的控制中发挥相反作用。
Br J Pharmacol. 1992 May;106(1):139-42. doi: 10.1111/j.1476-5381.1992.tb14306.x.
8
Bidirectional allosteric modulation of strychnine-sensitive glycine receptors by tropeines and 5-HT3 serotonin receptor ligands.托品烷类化合物和5-HT3血清素受体配体对士的宁敏感性甘氨酸受体的双向变构调节作用
Neuropharmacology. 1998 Dec;37(12):1633-41. doi: 10.1016/s0028-3908(98)00127-0.
9
[3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.[3H]ICS 205 - 930标记猫和兔迷走神经及颈上神经节膜中的5 - HT3识别位点。
Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):396-402. doi: 10.1007/BF00167040.
10
Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.通过放射性配体结合鉴定N1E-115神经母细胞瘤细胞膜中的5-羟色胺5-HT3识别位点。
Mol Pharmacol. 1988 Mar;33(3):303-9.

引用本文的文献

1
Preclinical and early clinical investigations related to monoaminergic pain modulation.与单胺能疼痛调制相关的临床前和早期临床研究。
Neurotherapeutics. 2009 Oct;6(4):703-12. doi: 10.1016/j.nurt.2009.07.009.
2
Characterisation of axon terminals in the rat dorsal horn that are immunoreactive for serotonin 5-HT3A receptor subunits.对大鼠背角中对5-羟色胺5-HT3A受体亚基呈免疫反应性的轴突终末的表征。
Exp Brain Res. 2003 Mar;149(1):114-24. doi: 10.1007/s00221-002-1339-7. Epub 2003 Jan 11.
3
Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system.
大鼠中枢神经系统和外周神经系统合成的5-羟色胺3受体的差异组成。
J Neurosci. 2002 Aug 1;22(15):6732-41. doi: 10.1523/JNEUROSCI.22-15-06732.2002.
4
[3H] GR67330, a very high affinity ligand for 5-HT3 receptors.[3H]GR67330,一种对5-羟色胺3受体具有极高亲和力的配体。
Naunyn Schmiedebergs Arch Pharmacol. 1990 Jul;342(1):22-30. doi: 10.1007/BF00178967.
5
Supersensitivity to intrathecal 5-hydroxytryptamine, but not noradrenaline, following depletion of spinal 5-hydroxytryptamine by 5,7-dihydroxytryptamine administered into various sites.通过向不同部位注射5,7-二羟基色胺耗尽脊髓5-羟色胺后,对鞘内注射5-羟色胺超敏,但对去甲肾上腺素不超敏。
Naunyn Schmiedebergs Arch Pharmacol. 1990 Jul;342(1):1-8. doi: 10.1007/BF00178964.
6
The serotonin 5-HT1D receptor: a progress review.血清素5-HT1D受体:进展综述。
Neurochem Res. 1990 Jun;15(6):567-82. doi: 10.1007/BF00973745.
7
5-HT3 receptor antagonists and migraine therapy.5-羟色胺3受体拮抗剂与偏头痛治疗
J Neurol. 1991;238 Suppl 1:S53-6. doi: 10.1007/BF01642907.